EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance

Ludovica Gaiaschi iD, Claudio Casali, Andrea Stabile, Sharon D'Amico, Mauro Ravera, Elisabetta Gabano, Andrea Galluzzo, Cristina Favaron, Federica Gola, Fabrizio De Luca, Serena Pellegatta, Maria Grazia Bottone

Cell Proliferation · 2025-06 · 58 (6)

DOI: 10.1111/cpr.13815 ↗

At a glance

Journal article in Cell Proliferation, published online on 2025-01-27. Written by Ludovica Gaiaschi and 11 co-authors. Institution: Department of Biology and Biotechnology, University of Pavia, Pavia, Italy. Major MEDLINE topics: Glioblastoma, Drug Resistance, Neoplasm, DNA Damage, DNA Repair. Cited 11 times so far (Crossref); 81 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Pavia with Fondi Ricerca Giovani, Immuno-HUB_DSM50, T4-CN-02, Immunotherapy: Treatment and Prevention of Infectious and Tumour Diseases.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Due to the lack of effective therapeutic approach, glioblastoma (GBM) remains one of the most malignant brain tumour. By in vitro investigations on primary GBM stem cells, we highlighted one of the underlying mechanisms of drug resistance to alkylating agents, the DNA damage responses. Here, flow cytometric analysis and viability and repopulation assays were used to assess the long‐term cytotoxic effect induced by the administration of a fourth‐generation platinum prodrug, the ( OC ‐6‐44)‐acetatodiamminedichlorido(2‐(2‐propynyl)octanoato) platinum(IV) named Pt(IV)Ac‐POA, in comparison to the most widely used Cisplatin. The immunofluorescence studies revealed changing pathways involved in the DNA damage response mechanisms in response to the two chemotherapies, suggesting in particular the role of Poly (ADP‐Ribose) polymerases in the onset of resistance to Cisplatin‐induced cytotoxicity. Thus, this research provides a proof of concept for how the use of a prodrug which allows the co‐administration of Cisplatin and an Histone DeACetylase inhibitors, could suppress DNA repair mechanisms, suggesting a novel effective approach in GBM treatment.

Subjects

MeSH terms (MEDLINE)

GlioblastomaDrug Resistance, NeoplasmDNA DamageDNA RepairBrain NeoplasmsAntineoplastic AgentsHumansCisplatinProdrugsCell Line, TumorCell Survival

Author keywords

DNA damage responsechemotherapydrug resistanceglioblastoma

Substances

CisplatinAntineoplastic AgentsProdrugs

Authors and institutions

  • Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
  • Department of Sciences and Technological Innovation (DiSIT), University of Piemonte Orientale "A. Avogadro", Alessandria, Italy.
  • Department of Sustainable Development and Ecological Transition, University of Piemonte Orientale, Vercelli, Italy.
  • Unit of Immunotherapy of Brain Tumors, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.

ORCID profiles: Ludovica Gaiaschi

Funding

  • University of Pavia with Fondi Ricerca Giovani
  • Immuno-HUB_DSM50, T4-CN-02, Immunotherapy: Treatment and Prevention of Infectious and Tumour Diseases

Cite

APA

Gaiaschi, L., Casali, C., Stabile, A., D'Amico, S., Ravera, M., Gabano, E., Galluzzo, A., Favaron, C., Gola, F., De Luca, F., Pellegatta, S., & Bottone, M. G. (2025). DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance. Cell Proliferation, 58(6). https://doi.org/10.1111/cpr.13815

Vancouver

Gaiaschi L, Casali C, Stabile A, D'Amico S, Ravera M, Gabano E, et al. DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance. Cell Proliferation. 2025;58(6). doi:10.1111/cpr.13815

BibTeX
@article{Gaiaschi2025,
  author = {Gaiaschi, Ludovica and Casali, Claudio and Stabile, Andrea and D'Amico, Sharon and Ravera, Mauro and Gabano, Elisabetta and Galluzzo, Andrea and Favaron, Cristina and Gola, Federica and De Luca, Fabrizio and Pellegatta, Serena and Bottone, Maria Grazia},
  title = {DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance},
  journal = {Cell Proliferation},
  year = {2025},
  volume = {58},
  number = {6},
  doi = {10.1111/cpr.13815}
}
Start for free →